DiscoverThe Big Con PodcastBrain Chemistry & Bottom Lines: The ROI of Neurodiversity
Brain Chemistry & Bottom Lines: The ROI of Neurodiversity

Brain Chemistry & Bottom Lines: The ROI of Neurodiversity

Update: 2024-11-26
Share

Description

From workplace stigma to corporate innovation - dive into the real talk about neurodiversity at work. When a major luxury retailer's neurodivergent discrimination case hits the headlines, we unpack the bigger picture: why embracing neurodivergent talent isn't just good ethics, it's smart business. Did you know neurodivergent testing teams are 30% more productive? Discover how companies like HP and the Australian Defence Force are tapping into unique cognitive perspectives for competitive advantage. Plus, real talk about masking, workplace accommodations, and why that "perfect cultural fit" might be costing your company billions in lost talent. Whether you're a leader, HR pro, or navigating neurodivergence yourself, this episode breaks down the mths, shares the stats, and shows how neurodiversity could be your organization's secret weapon.

📕Show Menu - https://bit.ly/bcpshowmenu

The Big Con Podcast: Emily and Dale are bringing you in on the Con. Strategy doesn't have to be something only those who master PowerPoint can do; we're making it approachable to everyone! The Big Con podcast is dedicated to demystifying and simplifying the world of strategy, exploring the businesses and individuals who've either harnessed it for success or missed the mark. 
Subscribe and follow today to get all new episodes in your feed immediately.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Brain Chemistry & Bottom Lines: The ROI of Neurodiversity

Brain Chemistry & Bottom Lines: The ROI of Neurodiversity

Dale Leszczynski